结果通过检索，共获得11篇相关文献，其中3篇随机对照试验，3篇病例对照试验和5篇病例报道。
Results By our searching; we got 11 papers including 3 randomized control trial; 3 case control trial and 5 other case reports.
研究设计：为试验一种新的诊断方法而做的预期病例对照研究。
Study Design. Prospectie case-control study testing a new diagnostic method.
现有的研究包括29个队列研究，69个病例对照研究以及4个随机临床试验。
Of the available studies, 29 were cohort studies, 69 case-control studies, and 4 randomized clinical trials.
这一结论不只是基于一些世代研究或病例对照研究，而是基于无数随机对照试验。
This isn't a conclusion based simply on some cohort or case-control studies. There are many, many randomized controlled trials.
结果：试验组和对照组完成病例分别为115例和113例（P>0.05）。
RESULTS: Treatment was completed in 115 and 113 cases in the experimental and control groups respectively (P>0.05).
随机对照试验：共完成合格病例456例，脑脉泰组343例，喜得镇组113例。
Randomized controlled trial: 456 eligible subjects have been collected, 343 in Naomaitai capsule group and 113 in hydergine tablet group.
第三、产品的疗效通常是通过病例报道或者采访患者展现，而不是设计良好的随机对照试验。
C. the effects are proven by some cases reports or patients interviews, but not the well-designed randomized controlled trials.
FDA是基于其两个随机对照临床试验的结果而认可这个药物的。病例数约为125例，患者至少事先接受过一项针对ITP的治疗。
FDA based its approval on two randomized clinical trials of about 125 patients who had received at least one prior ITP treatment.
共完成117例临床研究病例，其中试验组87例，对照组30例。
Total the completion be 117 clinical research case, among them experiment set 87, matched control 30.
采用诊断试验研究方法，分病例组和正常对照组。
All experiment objects were divided into the case group and the control group.
采用诊断试验研究方法，分病例组和正常对照组。
All experiment objects were divided into the case group and the control group.
应用推荐